IIARD International Institute of Academic Research and Development

INTERNATIONAL JOURNAL OF HEALTH AND PHARMACEUTICAL RESEARCH (IJHPR )

E-ISSN 2545-5737
P-ISSN 2695-2165
VOL. 10 NO. 4 2025
DOI: 10.56201/ijhpr.vol.10.no4.2025.pg75.88

---

Telemedicine Adoption Among Diabetes Patients in Nigeria

Ubah Emmanuel Maduka, Professor James Ebun Atolagbe

---

Abstract

Telemedicine, the remote delivery of healthcare services via digital communication technologies, has gained prominence in managing chronic diseases such as diabetes. Diabetes, a metabolic disorder characterized by chronic hyperglycemia, requires continuous monitoring, lifestyle adjustments, and timely medical interventions. The adoption of telemedicine presents an opportunity to improve access to healthcare, optimize glycemic control, and enhance patient self- management. This study investigates the adoption of telemedicine among diabetes patients, examining key factors influencing its utilization, perceived benefits, and existing barriers. The research aims to understand patient readiness, technological accessibility, and the role of healthcare providers in integrating telemedicine into diabetes care. A mixed-methods approach was employed, combining quantitative surveys and qualitative interviews with diabetes patients and healthcare professionals. Key variables analyzed include awareness, digital literacy, accessibility, affordability, healthcare infrastructure, provider engagement, patient adherence, and regulatory policies. The study reveals that telemedicine enhances healthcare accessibility, real-time blood glucose monitoring, patient education, medication adherence, and clinical outcomes. However, barriers such as limited internet connectivity, lack of technological literacy, data privacy concerns, affordability issues, and resistance from healthcare providers and patients hinder widespread adoption. Additionally, socioeconomic disparities influence telemedicine adoption, particularly in low-income regions with inadequate healthcare infrastructure. Telemedicine plays a transformative role in diabetes care by offering improved access to healthcare, real-time monitoring, personalized treatment plans, and enhanced patient engagement. Its ability to provide continuous care and early intervention not only improves blood g

keywords:

Telemedicine, Adoption, diabetes management, patients.

---

References:

Adebayo, J., Salami, T., & Uche, I. (2022). Telecom collaborations for digital healthcare
expansion in Africa. International Journal of Telemedicine, 14(4), 112-129.
Adebayo, O. A., et al. (2022). Barriers to telemedicine adoption in sub-Saharan Africa: A case
study of Nigeria. Telemedicine and e-Health, 28(5), 456–472.
Adebayo, O., et al. (2022). Barriers to Telemedicine Adoption in Sub-Saharan Africa: The Case
of Nigeria. African Journal of Digital Health, 5(2), 45-60.
Adeleke, T., Akinwale, O., & Ojo, M. (2022). Digital infrastructure and healthcare access in
Nigeria: Challenges and prospects. Journal of Health Informatics, 18(3), 45-60.
Adepoju, A. (2020). The integration of telemedicine into Nigerian medical education. Nigerian
Medical Journal, 55(2), 98-105.
Adepoju, A. (2022). Digital health innovations in Nigeria: The role of mDoc in chronic disease
management. Journal of Global Health, 12(4), 112-125.
Adesina, K., & Ibrahim, Y. (2023). Public-private partnerships in Nigeria’s healthcare technology
sector. African Journal of Public Health, 22(1), 33-47.
Agarwal, S., et al. (2021). The role of telehealth in diabetes care: Opportunities and challenges.
Journal of Diabetes Science and Technology, 15(3), 671–683.
Alwashmi, M. F. (2020). The use of digital health in diabetes management: A narrative review.
Cureus, 12(6), e8064.
American Diabetes Association (ADA). (2022). Standards of medical care in diabetes—2022.
Diabetes Care, 45(Supplement_1), S1–S2.
Bashshur, R. L., et al. (2021). Telemedicine for chronic disease management: Evidence and
implications. The Lancet Digital Health, 3(9), e575–e585.
Basu, S., et al. (2022). Impact of remote patient monitoring on diabetes outcomes: A systematic
review. Diabetes Research and Clinical Practice, 186, 109205.
Cefalu, W. T., et al. (2018). Telemedicine and diabetes care: A review of current evidence.
Diabetes Care, 41(5), 1020-1030.
Challenges. Journal of Diabetes & Metabolic Disorders, 20(2), 135–149.
Davis, R. M., et al. (2020). Artificial intelligence and remote diabetes care: Advances at the Mayo
Clinic. Journal of Telemedicine and Telecare, 26(3), 152-159.
Dorsey, E. R., & Topol, E. J. (2020). Telemedicine 2020 and beyond: Integrating telehealth into
practice. The Lancet, 395(10227), 859–862.
Ekpebegh, C. O., & Longo-Mbenza, B. (2021). Diabetes in Sub-Saharan Africa: Epidemiology
and
Eze, C., et al. (2022). Public Perception of Telemedicine in Nigeria: Awareness, Challenges, and
Prospects. Nigerian Medical Journal, 63(4), 200-215.
Eze, P., Chukwu, O., & Umeh, K. (2021). Barriers to telemedicine adoption in Nigeria: A patient-
centered approach. Nigerian Journal of Telehealth, 9(1), 25-39.
Fagherazzi, G., Ravaud, P., & Bonneton, L. (2019). Digital health strategies to fight diabetes:
Opportunities and challenges. Diabetes Care, 42(3), 379–385.
Fasanmade, O. A., & Odeniyi, I. A. (2020). Economic burden of diabetes in Nigeria: Costs and
policy implications. Journal of Health Economics and Outcomes Research, 7(1), 45–57.
Federal Ministry of Health (2022). Nigeria’s Telemedicine Policy Framework: Guidelines for
Implementation. Abuja, Nigeria.
Global Telehealth Initiative. (2023). Expanding Digital Health Access in Low-Income Regions.
Global Health Reports, 10(1), 89-105.
Greenhalgh, T., et al. (2020). Telemedicine in primary care: Lessons from COVID-19. BMJ, 368,
m998.
India Ministry of Health. (2023). eSanjeevani: Transforming healthcare access in rural India.
Government Health Report.
International Diabetes Federation (IDF). (2021). IDF Diabetes Atlas, 10th edition. Retrieved from
www.diabetesatlas.org
Izquierdo, R., Knudson, P. E., Meyer, S., Kearns, J., Ploutz-Snyder, R., & Weinstock, R. S. (2018).
A comparison of diabetes education administered through telemedicine versus in person.
Diabetes Care, 41(6), 1255–1260.
Kengne, A. P., Sobngwi, E., & Echouffo-Tcheugui, J. B. (2022). Diabetes complications in Africa:
Challenges and opportunities. The Lancet Diabetes & Endocrinology, 10(4), 251–260.
Koonin, L. M., et al. (2020). Trends in the use of telehealth during the COVID-19 pandemic.
JAMA, 324(11), 1150–1151.
Kumar, R., et al. (2022). Telemedicine in Resource-Limited Settings: Lessons from Developing
Countries. Journal of Telehealth and Medicine, 8(3), 112-128.
Kvedar, J., et al. (2021). Digital health and telemedicine in diabetes care: Barriers and future
directions. Diabetes Technology & Therapeutics, 23(4), 230–240.
Lee, S., O'Neill, J., Ihnat, D., & Conlon, M. (2020). Telemedicine diabetes consultations: An
effective approach to managing diabetes in rural areas. Journal of Diabetes Science and
Technology, 14(4), 758–764.
Misra, S., et al. (2023). Artificial Intelligence and mHealth in Diabetes Care: A Systematic
Review. Digital Health Perspectives, 9(2), 56-74.
Ngabo, F., et al. (2021). AI-powered telemedicine: Rwanda’s Babyl Health Initiative. African
Journal of Digital Health, 9(2), 75-90.
Nwachukwu, L., Ogunleye, B., & Afolabi, R. (2023). Community engagement strategies for
telemedicine awareness. Journal of African Digital Health, 11(2), 54-70.
Obi, E., & Aluko, D. (2023). Innovations in Nigerian telemedicine: A case study of local startups.
Nigerian Journal of Health Technology, 7(3), 85-102.
OECD. (2022). Telemedicine regulatory frameworks: Insights from OECD countries. OECD
Health Policy Studies.
Ogunleye, O. O., Basu, D., & Wushishi, A. (2020). Challenges in diabetes care and policy
implementation in Nigeria. BMC Health Services Research, 20(1), 789.
Ogunleye, T., et al. (2023). Training Healthcare Workers for the Digital Age: The Nigerian
Experience. Journal of Medical Technology, 7(1), 145-160.
Okafor, C., Adebanjo, T., & Hassan, R. (2023). Healthcare provider incentives for digital health
integration. West African Medical Journal, 19(4), 67-81.
Okonkwo, P., & Adeyemi, S. (2023). The role of language accessibility in telemedicine adoption
in Nigeria. Journal of Multilingual Digital Health, 5(2), 40-55.
Sharma, A., et al. (2021). Barriers to telemedicine adoption among patients with diabetes: A
systematic review. Journal of Telemedicine and Telecare, 27(4), 195–206.
Sharma, P., et al. (2021). The Role of Telemedicine in Diabetes Management: A Meta-Analysis.
International Journal of Diabetes Research, 15(4), 230-245.
Smith, P. M., et al. (2019). Diabetes Telehealth Network: A rural Australian model for chronic
disease management. Australian Journal of Telemedicine, 27(1), 45-58.
Wang, J., et al. (2021). Impact of Telemedicine on Diabetes Control: A Review of Clinical
Evidence. Journal of Endocrinology and Metabolism, 26(3), 300-320.
World Bank. (2022). Health indicators in Nigeria: Prevalence and burden of diabetes. Retrieved
from www.worldbank.org.
World Health Organization (WHO). (2021). Digital health and telemedicine in sub-Saharan
Africa: Policy recommendations. Geneva: WHO Press.
World Health Organization (WHO). (2023). Global report on telemedicine and digital health.
World Health Organization. (2021). Digital Health Strategies for Universal Health Coverage:
Global Telehealth Report. Geneva: WHO.
Zhai, Y., et al. (2022). The effectiveness of telemedicine in diabetes management: A meta-analysis.
Journal of Medical Internet Research, 24(3), e33178.

DOWNLOAD PDF

---

Back